The GrayMatterAI Data Analytics Platform

OUR COGNITIVE DATA ANALYTICS PLATFORM PROVIDES
A PATIENT LEVEL 360 VIEW AND CLINICAL OUTCOME MODEL WITH
POPULATION LEVEL FORECASTING BASED ON PATIENT DATA

HEPATITIS C PRODUCT

Our HepC Product provides specialty drug prescribing decision support. Using real world evidence and individual patient data, our AI driven analytics provide specialty drug prescribing support that optimize clinical and cost outcomes while adhering to clinical best practice

PATENT-PENDING AI LEARNING ENGINE

GrayMatterAI has built a learning engine that can ingest patient data from multiple sources to build a holistic model of a disease state. This model can then be used to answer questions from Payers, Providers and Pharma backed up by Big Data analytics

WITH GRAYMatterAI, CLINICAL
INSIGHTS ARE ONLY THE BEGINNING

GrayMatterAI is a learning platform that continues to learn and
get better with time as more and more data is seen by the system and
automatically alerts you to patterns, insights, and opportunities